DSCSA: A Blessing or a Curse?
Embracing the DSCSA is not merely about meeting regulatory requirements; it is an opportunity to elevate the standard of care and operational excellence within pharmacy.
Will Lockwood
Top 10 Features to Look for in Compounding Software
Selecting the right software for your compounding pharmacy is a decision that impacts every aspect of your operations — from patient care to inventory management.
Podcasts
LucyRx: A New PBM Partner Actively Supporting Independent Pharmacies?
A "next-generation" and independent PBM aiming to redefine the industry.
Newsletter
PrimeRx Releases In-Depth White Paper on the Critical Need for PBM Reform and Technology Solutions for Pharmacies
White Paper | Learn how pharmacy benefit managers (PBMs) are impacting community pharmacies and how technology like PrimeRx can help mitigate these challenges. | Sponsored
The National Community Pharmacists Association (NCPA) 2024 Annual Convention and Expo
The NCPA 2024 Annual Convention and Expo in October in Columbus, Ohio, offered members three days of wide-ranging educational programming.
Newsletter
Is Pharmacy Benefit Manager Reform in Danger?
PBM Reform at a frustrating standoff despite overwhelming support.
SoftWriters‘ FrameworkLTC 14th Annual User Conference
The theme of the FrameworkLTC 14th Annual User Conference in Las Vegas in October 2024 was “Accelerating Innovation,” was a nod to both (AI) and the company’s commitment to innovation.
SoftWriters Teams with C2 Keep for Fully Integrated Compliance Tool
Strategic integration between FrameworkLTC and C2 Keep, a leading cloud-based solution for controlled substance compliance and inventory management.
The Power of Collaboration: Why AI Summits Matter
SoftWriters participated in the Feb. 12, 2025, summit through an insightful breakout session led by Terry Dean, Director of Product Operations and Execution.
Podcasts
Pharmacy News Deep Dive: NCPA Digest 2024, AI Scribes, and $2 Drugs
Insights from the 2024 NCPA Digest; the opportunity and risks of AI scribes in pharmacy; and what CMS' $2 drug list means for pharmacies.
Pharmacy Services Continue in Turbulent Times
Pharmacy trends in 2024 NCPA Digest: Reimbursement strain, staffing shortages, closures, expanded services, and community focus highlighted. | Catalyst Corner
Is CMS’ Proposed $2 Drug List Model Another Hit to Pharmacies?
CMS sees an opportunity to increase beneficiary access to $2 copays for a standardized list of generics across participating plans. | Viewpoints